Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
16.08
-0.94 (-5.52%)
Dec 30, 2024, 11:48 AM EST - Market open
ARCT Employees
Arcturus Therapeutics Holdings had 180 employees as of December 31, 2023. The number of employees increased by 10 or 5.88% compared to the previous year.
Employees
180
Change (1Y)
10
Growth (1Y)
5.88%
Revenue / Employee
$891,106
Profits / Employee
-$348,017
Market Cap
435.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ARCT News
- 13 days ago - Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Arcturus Therapeutics to Present at Jefferies London Healthcare Conference - Business Wire
- 6 weeks ago - Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data - Seeking Alpha
- 6 weeks ago - Meiji Seika Pharma Announces Investment in ARCALIS, Inc. - Business Wire
- 6 weeks ago - Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial - Business Wire
- 7 weeks ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress - Business Wire